Difference between revisions of "Marechal R, et al. Br. J. Cancer (2009) cited as Ref 738 in DOI: 10.1038/s41392-020-0110-5 (Q10001)"
Jump to navigation
Jump to search
(Created claim: Volume (P103): 100, #quickstatements; #temporary_batch_1590009084631) |
(Created claim: title (P93): High expression of CXCR4 may predict poor survival in resected pancreatic adenocarcinoma, #quickstatements; #temporary_batch_1590010982689) |
||
| Property / title | |||
| + | High expression of CXCR4 may predict poor survival in resected pancreatic adenocarcinoma (English) | ||
| Property / title: High expression of CXCR4 may predict poor survival in resected pancreatic adenocarcinoma (English) / rank | |||
| + | Normal rank | ||
Revision as of 22:07, 20 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Marechal R, et al. Br. J. Cancer (2009) cited as Ref 738 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Marechal R
0 references
2009
0 references
Br. J. Cancer
0 references
100
0 references
High expression of CXCR4 may predict poor survival in resected pancreatic adenocarcinoma (English)
0 references
